NL-OMON27800招募中不适用
Pancreatic Locally advanced Irresectable Cancer Ablation in the Netherlands
Olympus Medical Systems: CelonPowerSystem; CelonProSurge probes0 个研究点目标入组 228 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 228
研究概览
简要总结
not yet
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Histologically or cytologically confirmed adenocarcinoma of the pancreas
- •2.Locally irresectable tumor (according to the Dutch Pancreatic Cancer Group criteria; www.dpcg.nl)
排除标准
- •1.WHO performance status ≥ 3
- •2.Distant metastases on abdominal or thoracic CT scan*
研究者
相似试验
招募中
不适用
Pancreatic Locally advanced Irresectable Cancer AblatioN (PELICAN trial)Locally advanced pancreatic cancernon-resectabel pancreatic tumor10017998NL-OMON56404Amsterdam UMC174
进行中（未招募）
1 期
ocally Advanced Pancreatic Cancer: Phase II study of cetuximab and 3-D conformal image-guided radiotherapy (PACER Study) - PACER StudyEUCTR2006-001742-13-GBChristie Hospital NHS Trust44
进行中（未招募）
不适用
Neoadjuvant Treatment of Resectable or Locally Advanced Borderline Pancreatic Adenocarcinoma: Reproducibility of Tumor Measurement in CT VS MRIPancreas CancerAdenocarcinomaNCT05511116Fondation Hôpital Saint-Joseph48
已完成
1 期
Regional Chemotherapy in Locally Advanced Pancreatic Cancer: RECLAP TrialHistologically or Cytologically Confirmed Pancreatic CaUnresectable or Borderline Resectable Pancreatic CaNCT01294358National Cancer Institute (NCI)7
Unknown
不适用
VENous Invasion in PANcreatic CancerPancreatic cancerNL-OMON27194MC500